Home » Clinical Trials » Search Clinical Trials
Parent Therapeutic Areas: Immunology/Infectious Diseases | Pulmonary/Respiratory Diseases | Pediatrics/Neonatology

Influenza

Alabama

Birmingham : Research Site:

A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Arkansas

Little Rock : Research Site:

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

California

Paramount : Center for Clinical Trials, LLC

¿Piensa Que Tiene Una GRIPE? Entonces Mire Esto.

Paramount : Center for Clinical Trials, LLC

IS it looking like the FLU? THEN READ THIS.

Paramount : Center for Clinical Trials, LLC

IS it looking like the FLU? THEN READ THIS.

Colorado

Denver : Research Site:

A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Delaware

Newark : Research Site:

A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Florida

Clearwater : Tampa Bay Medical Research, Inc

Pneumonia Vaccine/Flu Vaccine Research Study

St Petersburg : Research Site:

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

West Palm Beach : Research Site:

A Study of Tamiflu (Oseltamivir) for Seasonal Prophylaxis of Influenza in Children.

Illinois

Chicago : Research Site:

A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Chicago : Research Site:

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Chicago : Research Site:

IRIS: An Influenza Resistance Information Study

Massachusetts

Springfield : Research Site:

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Michigan

Ann Arbor : Research Site:

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Detroit : Research Site:

A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Detroit : Research Site:

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Minnesota

Brooklyn Center : Research Site:

A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Montana

Missoula : Research Site:

A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

New Jersey

Hackensack : Research Site:

A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

North Carolina

Winston-Salem : Research Site:

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

North Dakota

Fargo : Odyssey Research Services

A ParaInfluenza Virus Type III Vaccine Study

Ohio

Cincinnati : Research Site:

A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Cleveland : Research Site:

A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Cleveland : Research Site:

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Oklahoma

Oklahoma City : Research Site:

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Pennsylvania

Philadelphia : Research Site:

A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Philadelphia : Research Site:

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Pittsburgh : Research Site:

A Study of Tamiflu (Oseltamivir) for Seasonal Prophylaxis of Influenza in Children.

Pittsburgh : Research Site:

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Tennessee

Jackson : Research Site:

A Study of Tamiflu (Oseltamivir) for Seasonal Prophylaxis of Influenza in Children.

Texas

Dallas : Research Site:

A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Dallas : Research Site:

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Houston : Research Site:

A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Houston : Research Site:

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Lubbock : Research Site:

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Utah

Salt Lake City : Research Site:

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Belgium

Aalst : Research Site:

A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Bruxelles : Research Site:

A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Edegem : Research Site:

A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Leuven : Research Site:

A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Bulgaria

Plovdiv : Research Site:

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Sofia : Research Site:

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Canada

Coquitlam, BC : Research Site:

A Study of Tamiflu (Oseltamivir) for Seasonal Prophylaxis of Influenza in Children.

Saskatoon, SK : Research Site:

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Estonia

Tallinn : Research Site:

A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Tartu : Research Site:

A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

France

Paris : Research Site:

A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Toulouse : Research Site:

A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Toulouse : Research Site:

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Tours : Research Site:

A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Germany

Aachen : Research Site:

A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Heidelberg : Research Site:

A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Heidelberg : Research Site:

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

München : Research Site:

A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Greece

Athens : Research Site:

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Hungary

Budapest : Research Site:

A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Pecs : Research Site:

A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Szeged : Research Site:

A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Israel

Haifa : Research Site:

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Jerusalem : Research Site:

A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Petach Tikva : Research Site:

A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Petach Tikva : Research Site:

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Ramat Gan : Research Site:

A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Ramat Gan : Research Site:

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Italy

Padova : Research Site:

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Pavia : Research Site:

A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Roma : Research Site:

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Latvia

Riga : Research Site:

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Lithuania

Kaunas : Research Site:

A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Vilnius : Research Site:

A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Poland

Bialystok : Research Site:

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Spain

Madrid : Research Site:

A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Switzerland

Zuerich : Research Site:

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Ukraine

Kiev : Research Site:

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Lugnansk : Research Site:

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Zaporozhye : Research Site:

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

United Kingdom

Birmingham : Research Site:

A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Nottingham : Research Site:

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.